CA988424A - Pharmaceutical compositions of n-acylaminophenol in a suitable form for tabletting - Google Patents

Pharmaceutical compositions of n-acylaminophenol in a suitable form for tabletting

Info

Publication number
CA988424A
CA988424A CA150,153A CA150153A CA988424A CA 988424 A CA988424 A CA 988424A CA 150153 A CA150153 A CA 150153A CA 988424 A CA988424 A CA 988424A
Authority
CA
Canada
Prior art keywords
acylaminophenol
tabletting
pharmaceutical compositions
suitable form
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA150,153A
Other versions
CA150153S (en
Inventor
Christopher G. Barlow
John W. Harrison
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
STWB Inc
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Application granted granted Critical
Publication of CA988424A publication Critical patent/CA988424A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
CA150,153A 1971-08-27 1972-08-25 Pharmaceutical compositions of n-acylaminophenol in a suitable form for tabletting Expired CA988424A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4042771A GB1390032A (en) 1971-08-27 1971-08-27 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
CA988424A true CA988424A (en) 1976-05-04

Family

ID=10414863

Family Applications (1)

Application Number Title Priority Date Filing Date
CA150,153A Expired CA988424A (en) 1971-08-27 1972-08-25 Pharmaceutical compositions of n-acylaminophenol in a suitable form for tabletting

Country Status (7)

Country Link
AU (1) AU4584572A (en)
CA (1) CA988424A (en)
DE (1) DE2241960C2 (en)
DK (1) DK131418B (en)
FR (1) FR2150903B1 (en)
GB (1) GB1390032A (en)
ZA (1) ZA725791B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE17650T1 (en) * 1980-05-20 1986-02-15 Mallinckrodt Inc DRY POWDERED N-ACETYL-P-AMINOPHENOL COMPOSITIONS AND PROCESS FOR THEIR PREPARATION.
AR226763A1 (en) * 1980-12-22 1982-08-13 Monsanto Co PREPARATION METHOD FOR AN ANALGESIC GRANULATION OF ACETAMINOPHEN
DE3215211A1 (en) * 1982-04-23 1983-10-27 Akzo Gmbh MICROPOROISIS POWDER LOADED WITH ACTIVE SUBSTANCES
IE55579B1 (en) * 1982-07-06 1990-11-07 Sterwin Ag Processes for preparing tablets by a modified'wet-granulation'technique
US4562024A (en) * 1982-07-06 1985-12-31 Sterling Drug Inc. Process for preparing granulate containing poorly compressible medicinally active matter
US4600579A (en) * 1983-06-07 1986-07-15 Mallinckrodt, Inc. N-acetyl-p-aminophenol compositions containing partially gelatinized starch and method for preparing same
US4684516A (en) * 1983-08-01 1987-08-04 Alra Laboratories, Inc. Sustained release tablets and method of making same
US4661521A (en) * 1984-04-30 1987-04-28 Mallinckrodt, Inc. Direct tableting acetaminophen compositions
US4631284A (en) * 1984-11-19 1986-12-23 Mallinckrodt, Inc. Acetaminophen compositions containing low doses of chlorpheniramine maleate, method for preparing same and tablets formed therefrom
DE3447422A1 (en) * 1984-12-24 1986-06-26 Basf Ag, 6700 Ludwigshafen METHOD FOR THE PRODUCTION OF ASCORBIN ACID GRANULES
US4757090A (en) * 1986-07-14 1988-07-12 Mallinckrodt, Inc. Direct tableting acetaminophen compositions
JPH0780754B2 (en) * 1986-08-06 1995-08-30 エーザイ株式会社 Multi-granular sustained-release tablet
US4820522A (en) * 1987-07-27 1989-04-11 Mcneilab, Inc. Oral sustained release acetaminophen formulation and process
US4837031A (en) * 1987-09-17 1989-06-06 Mallinckrodt, Inc. Compositions containing ibuprofen
GB9305058D0 (en) * 1993-03-12 1993-04-28 Penn Pharm Ltd Pharmaceutical compositions
DE19835124C2 (en) * 1998-08-04 2002-01-03 Buna Sow Leuna Olefinverb Gmbh Process for the production of starch esters with a defined grain structure for pharmaceutical purposes
EP2813220A3 (en) 2010-04-09 2015-06-17 Pacira Pharmaceuticals, Inc. Method for formulating large diameter synthetic membrane vesicles

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3200039A (en) * 1962-05-28 1965-08-10 Pfizer & Co C Non-granulated tablets with 20% sorbitol in a particle size of from about 100mu to about 2000mu

Also Published As

Publication number Publication date
DE2241960C2 (en) 1982-02-04
FR2150903B1 (en) 1975-10-17
ZA725791B (en) 1973-05-30
DK131418C (en) 1975-12-01
DE2241960A1 (en) 1973-03-15
GB1390032A (en) 1975-04-09
FR2150903A1 (en) 1973-04-13
DK131418B (en) 1975-07-14
AU4584572A (en) 1974-02-28

Similar Documents

Publication Publication Date Title
AU482733B2 (en) Pharmaceutical compositions
CA983854A (en) Pharmaceutical composition containing nitroglycerin
CA988424A (en) Pharmaceutical compositions of n-acylaminophenol in a suitable form for tabletting
CA1036072A (en) Absorption-promoting pharmaceutical oral compositions
IE35991L (en) Camphor-containing pharmaceutical composition
HK69276A (en) Pharmaceutical compositions
CA974170A (en) Pharmaceutical compositions
ZA718326B (en) Pharmaceutical composition
AU461136B2 (en) Pharmaceutical composition
CA975297A (en) Pharmaceutical composition containing a high percentage of allopurinol
CA883791A (en) Spasmolytic pharmaceutical compositions
AU4615772A (en) Iodophor-steroid pharmaceutical compositions
AU464275B2 (en) Pharmaceutical compositions comprising esters of 9-fluoro-16-methylene-prednisolone
CA881476A (en) Pharmaceutical compositions
CA884860A (en) Pharmaceutical compositions
CA879074A (en) Pharmaceutical compositions
CA876689A (en) Pharmaceutical compositions
CA888688A (en) Pharmaceutical compositions
CA888155A (en) Pharmaceutical compositions
CA884856A (en) Pharmaceutical compositions
CA882088A (en) Pharmaceutical compositions
CA884857A (en) Pharmaceutical composition
CA885421A (en) Pharmaceutical composition
IL39100A0 (en) Novel pyrrolidine derivatives their preparation and pharmaceutical compositions containing them
CA866178A (en) Pharmaceutical compositions and their preparation